Treatment of Impending Tumor Lysis with Single-Dose Rasburicase

Annals of Pharmacotherapy

Volumn 37, Issue 11, 2003, Pages 1614-1617

  Lee, Anselm C W ^a   Li, Chak H ^a   So, Kwan T ^a   Chan, Regina ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Acute lymphoblastic leukemia; Hyperuricemia; Rasburicase; Tumor lysis syndrome

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE; PREDNISOLONE; RASBURICASE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CHILDHOOD LEUKEMIA; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYDRATION; HYPERURICEMIA; KIDNEY FUNCTION; LEUKEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; HYPERURICEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; TUMOR LYSIS SYNDROME; URATE OXIDASE; URIC ACID;

EID: 0142244573     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D111     Document Type: Article

References (8)

1. Jones DP, Mahmoud H, Chesney RW. Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 1995;9:206-12.
2. Mahmoud HH, Leverger G, Patte C, Harvey E, Lascombes F. Advances in the management of malignancy-associated hyperuricaemia. Br J Cancer 1998;77(suppl 4):18-20.
3. Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 2001;19:697-704.
4. Easton J, Noble S, Jarvis B. Rasburicase. Pediatr Drugs 2001;3:433-7.
5. Pui CH, Jeha S, Irwin D, Camitta B. Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. Leukemia 2001;15:1505-9.
6. Pui CH, Relling MV, Lascombes F, Harrison PL, Struxiano A, Mondesir JM, et al. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia 1997;11:1813-6.
7. Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001;97:2998-3003.
8. Rasburicase (Elitek) for hyperuricemia. Med Lett Drugs Ther 2002;44:96-7.